First Tracks Biotherapeutics, Inc. (TRAX) KPIs and segments
TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$43.57−2.99 (-6.42%)
Close on Nov 17, 2026Market cap $1.56BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive First Tracks Biotherapeutics's business
Coming soon
This tab will track the numbers specific to First Tracks Biotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?